ABUS
Arbutus Biopharma Corp · Healthcare · Biotechnology
Momentum-Eingaben (vergleichbare Manager): Halterbreite 0.0% · Aktienfluss +3.6% · neue Nettopositionen 0.0% — Formel
Alle Eigentumszahlen: nur beobachtete 13F-Manager, Stammaktienpositionen, Berichtszeitraum Q3 2025
| Quartal | Inhaber | Δ | Aktien | Gemeldeter Wert | Neu | Ausstiege |
|---|---|---|---|---|---|---|
| Q2 2026 | 75 | +3 | 78.82M | $378.29M | +13 | −10 |
| Q1 2026 | 75 | -5 | 80.64M | $362.88M | +5 | −10 |
| Q4 2025 | 79 | -1 | 77.73M | $373.87M | — | −1 |
| Q3 2025 | 16 | 0 | 63.04M | $286.21M | +1 | −1 |
| Q2 2025 | 13 | +1 | 34.03M | $105.14M | +1 | — |
| Q1 2025 | 9 | 0 | 10.62M | $37.08M | — | — |
| Q4 2024 | 9 | 0 | 11.43M | $37.37M | — | — |
| Q3 2024 | 8 | +1 | 7.82M | $30.10M | +1 | — |
| Q2 2024 | 7 | — | 7.20M | $22.26M | — | — |
| # | Manager | Aktien | Δ Anteile | Wert | Deren Gewichtung | Gehalten | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Morgan Stanley ✦ | 24.45M | — | $111.01M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Morgan Stanley ✦ | 24.45M | — | $111.01M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Morgan Stanley ✦ | 24.45M | — | $111.01M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Morgan Stanley ✦ | 24.45M | — | $111.01M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | Morgan Stanley ✦ | 24.45M | — | $111.01M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | Morgan Stanley ✦ | 24.45M | — | $111.01M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | Morgan Stanley ✦ | 24.45M | — | $111.01M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | BlackRock ✦ (passiv) | 12.68M | -1.5% | $57.56M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 9 | BlackRock ✦ (passiv) | 12.68M | -1.5% | $57.56M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 10 | BlackRock ✦ (passiv) | 12.68M | -1.5% | $57.56M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 11 | BlackRock ✦ (passiv) | 12.68M | -1.5% | $57.56M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 12 | BlackRock ✦ (passiv) | 12.68M | -1.5% | $57.56M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 13 | BlackRock ✦ (passiv) | 12.68M | -1.5% | $57.56M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 14 | BlackRock ✦ (passiv) | 12.68M | -1.5% | $57.56M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 15 | BlackRock ✦ (passiv) | 12.68M | -1.5% | $57.56M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 16 | BlackRock ✦ (passiv) | 12.68M | -1.5% | $57.56M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 17 | BlackRock ✦ (passiv) | 12.68M | -1.5% | $57.56M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 18 | The Vanguard Group ✦ (passiv) | 8.99M | -1.0% | $40.82M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 19 | The Vanguard Group ✦ (passiv) | 8.99M | -1.0% | $40.82M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 20 | The Vanguard Group ✦ (passiv) | 8.99M | -1.0% | $40.82M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 21 | The Vanguard Group ✦ (passiv) | 8.99M | -1.0% | $40.82M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 22 | The Vanguard Group ✦ (passiv) | 8.99M | -1.0% | $40.82M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 23 | Adage Capital Partners ✦ | 5.01M | +94.7% | $22.77M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 24 | State Street Global Advisors ✦ (passiv) | 4.10M | -8.1% | $18.61M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 25 | Geode Capital Management ✦ (passiv) | 3.67M | +0.8% | $16.65M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 26 | Geode Capital Management ✦ (passiv) | 3.67M | +0.8% | $16.65M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 27 | Goldman Sachs Group ✦ | 2.17M | — | $9.87M | 0.0% | n/c | 1 | SEC ↗ |
| 28 | Goldman Sachs Group ✦ | 2.17M | — | $9.87M | 0.0% | n/c | 1 | SEC ↗ |
| 29 | Millennium Management ✦ | 528.34K | +5.8% | $2.40M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 30 | Wellington Management ✦ | 514.08K | -3.3% | $2.33M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 31 | Wellington Management ✦ | 514.08K | -3.3% | $2.33M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 32 | Wellington Management ✦ | 514.08K | -3.3% | $2.33M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 33 | JPMorgan Chase ✦ | 196.46K | — | $891,918 | 0.0% | n/c | 1 | SEC ↗ |
| 34 | JPMorgan Chase ✦ | 196.46K | — | $891,918 | 0.0% | n/c | 1 | SEC ↗ |
| 35 | JPMorgan Chase ✦ | 196.46K | — | $891,918 | 0.0% | n/c | 1 | SEC ↗ |
| 36 | JPMorgan Chase ✦ | 196.46K | — | $891,918 | 0.0% | n/c | 1 | SEC ↗ |
| 37 | JPMorgan Chase ✦ | 196.46K | — | $891,918 | 0.0% | n/c | 1 | SEC ↗ |
| 38 | JPMorgan Chase ✦ | 196.46K | — | $891,918 | 0.0% | n/c | 1 | SEC ↗ |
| 39 | JPMorgan Chase ✦ | 196.46K | — | $891,918 | 0.0% | n/c | 1 | SEC ↗ |
| 40 | JPMorgan Chase ✦ | 196.46K | — | $891,918 | 0.0% | n/c | 1 | SEC ↗ |
| 41 | JPMorgan Chase ✦ | 196.46K | — | $891,918 | 0.0% | n/c | 1 | SEC ↗ |
| 42 | JPMorgan Chase ✦ | 196.46K | — | $891,918 | 0.0% | n/c | 1 | SEC ↗ |
| 43 | Citadel Advisors ✦ | 193.69K | +61.0% | $879,357 | 0.0% | ▲ Add | 6 | SEC ↗ |
| 44 | D. E. Shaw & Co. ✦ | 189.95K | +366.7% | $862,382 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 45 | D. E. Shaw & Co. ✦ | 189.95K | +366.7% | $862,382 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 46 | Arrowstreet Capital ✦ | 159.12K | Neu | $722,396 | 0.0% | New | 1 | SEC ↗ |
| 47 | Fidelity (FMR) ✦ | 89.46K | +10.8% | $406,165 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 48 | Fidelity (FMR) ✦ | 89.46K | +10.8% | $406,165 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 49 | T. Rowe Price ✦ | 83.01K | +8.5% | $377,000 | 0.0% | ▲ Add | 6 | SEC ↗ |
| 50 | AQR Capital Management ✦ | 15.23K | -59.6% | $69,158 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 51 | AQR Capital Management ✦ | 15.23K | -59.6% | $69,158 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 52 | AQR Capital Management ✦ | 15.23K | -59.6% | $69,158 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 53 | AQR Capital Management ✦ | 15.23K | -59.6% | $69,158 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 54 | AQR Capital Management ✦ | 15.23K | -59.6% | $69,158 | 0.0% | ▼ Trim | 5 | SEC ↗ |
„Ihre Gewichtung" = Anteil der Position am gemeldeten 13F-Eigenkapitalwert des jeweiligen Managers — das Conviction-Maß. ✦ = kuratorisch ausgewählter Manager.
Neue Käufer
| Arrowstreet Capital | $722,396 | 0.0% |
Ausgestiegen
| Two Sigma Investments | $34,914 | war 0.0% |
Marktweiter Kontext: über ALLE 13F-Melder (strukturierte SEC-Daten, Q1 2026): 166 Inhaber, 138.84M Anteile, $623.91M gemeldet. Dies ist ein anderer, älterer Zeitraum als die oben genannten Zahlen des erfassten Universums; beide werden niemals vermischt.
Was die erfassten Halter dieses Wertpapiers am häufigsten sonst noch halten — Zählungen gemeinsamer Eigentümerschaft, keine fundamentalen Zusammenhänge.